62 related articles for article (PubMed ID: 6127291)
1. [The hypotensive effects and mechanism of SGB-483, a newly-synthesized hypotensive agent].
Chin W; Nakagawa Y; Mitomi A; Imai S
Nihon Yakurigaku Zasshi; 1982 May; 79(5):441-9. PubMed ID: 6127291
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of the hypotensive effect of a novel phenylpiperazine derivative, SGB-1534: antagonism at alpha 1-adrenergic and 5-HT2 receptors.
Aono J; Nabata H; Ishizuka N; Sakai K
Arch Int Pharmacodyn Ther; 1985 Sep; 277(1):126-39. PubMed ID: 2865933
[TBL] [Abstract][Full Text] [Related]
3. The hypotensive effect of trimazosin is not caused solely by alpha 1-adrenoceptor blockade.
Constantine JW; Lebel W; Weeks R
J Cardiovasc Pharmacol; 1984; 6(1):142-50. PubMed ID: 6199597
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular effects and interaction with adrenoceptors of urapidil.
van Zwieten PA; de Jonge A; Wilffert B; Timmermans PB; Beckeringh JJ; Thoolen MJ
Arch Int Pharmacodyn Ther; 1985 Aug; 276(2):180-201. PubMed ID: 4051641
[TBL] [Abstract][Full Text] [Related]
5. Investigations into the mechanism of the antihypertensive effect of SGB-1534, a novel alpha 1-adrenoceptor antagonist, in rats.
Aono J; Sakai K
Jpn J Pharmacol; 1988 Oct; 48(2):229-39. PubMed ID: 2905394
[TBL] [Abstract][Full Text] [Related]
6. Alpha-adrenoceptor antagonistic effects and antihypertensive activity of SGB-1534 in conscious normotensive and deoxycorticosterone acetate (DOCA)-salt hypertensive dogs: comparison with prazosin.
Haruta K; Baba A; Akima M; Koga T; Shiraki Y; Sakai K
Arch Int Pharmacodyn Ther; 1989; 299():169-84. PubMed ID: 2570554
[TBL] [Abstract][Full Text] [Related]
7. Antihypertensive effects of a novel phenylpiperazine derivative, SGB-1534, on several hypertensive models of rats.
Nabata H; Aono J; Ishizuka N; Sakai K
Arch Int Pharmacodyn Ther; 1985 Sep; 277(1):104-18. PubMed ID: 3904651
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological profile of a new beta-adrenoceptor blocker, 4-[3-(tert-butylamino)-2-hydroxypropoxy]-N-methylisocarbostyril hydrochloride (N-696).
Nakagawa Y; Sugai T; Chin WP; Shibuya T; Hashimoto K; Imai S
Arzneimittelforschung; 1984; 34(2):194-9. PubMed ID: 6144313
[TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamic effects of a 2-piperazinotetralin (P-11)--combined alpha- and beta-adrenoceptor blocking drug with hypotensive action.
Mutafova-Yambolieva V; Staneva-Stoytcheva D
Methods Find Exp Clin Pharmacol; 1988 Sep; 10(9):551-7. PubMed ID: 2906393
[TBL] [Abstract][Full Text] [Related]
10. Effects of SGB-1534, a new synthesized phenylpiperazine derivative, on blood pressure and heart rate in stroke-prone spontaneously hypertensive rats.
Matsumoto M; Yoshioka M; Togashi H; Minami M; Nagao A; Saito H
Hokkaido Igaku Zasshi; 1988 Jan; 63(1):36-43. PubMed ID: 2896150
[TBL] [Abstract][Full Text] [Related]
11. Analysis of adrenoceptor blockade and hypotension elicited by urapidil and prazosin in conscious rat.
Goering J; Zimmerman BG
J Pharmacol Exp Ther; 1986 May; 237(2):553-7. PubMed ID: 2871176
[TBL] [Abstract][Full Text] [Related]
12. Functional and biochemical evidence for the lack of cardiac presynaptic alpha-2 adrenoceptor stimulant properties of cirazoline (LD 3098), a potent alpha-1 adrenoceptor agonist in dogs and rats.
Cavero I; Lefèvre-Borg F; Roach AG; Gomeni R; Scatton B
J Pharmacol Exp Ther; 1982 Oct; 223(1):241-50. PubMed ID: 6126583
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of depression by clonidine of the pressor response to alpha 1-adrenoceptor agonists in pithed rats.
Nomura S; Sunagane N; Uruno T; Kubota K
Res Commun Mol Pathol Pharmacol; 1996 Mar; 91(3):273-86. PubMed ID: 8829767
[TBL] [Abstract][Full Text] [Related]
14. Evidence for adrenergic and tachykinin activity in venom of the stonefish (Synanceja trachynis).
Hopkins BJ; Hodgson WC; Sutherland SK
Toxicon; 1996 May; 34(5):541-54. PubMed ID: 8783449
[TBL] [Abstract][Full Text] [Related]
15. An alpha-adrenoceptor-blocking action of SGB-483, a new piperazine antihypertensive agent in isolated vascular smooth muscles.
Satake N; Shibata S; Suh TK; Flores F
Blood Vessels; 1984; 21(6):298-305. PubMed ID: 6149779
[TBL] [Abstract][Full Text] [Related]
16. [Antihypertensive effect of guanfacine in rats].
Nakagawa Y; Takeda K; Hashimoto T; Sakurai H; Mitomi A; Imai S; Hamamura M; Kumada M
Nihon Yakurigaku Zasshi; 1981 Mar; 77(3):295-312. PubMed ID: 6762984
[TBL] [Abstract][Full Text] [Related]
17. [Cardiovascular effects of urapidil].
Bousquet P; Decker N; Feldman J; Schwartz J
J Pharmacol; 1983; 14(4):465-72. PubMed ID: 6672466
[TBL] [Abstract][Full Text] [Related]
18. Effects of urapidil on blood pressure and adrenoceptors in various animal models.
van Zwieten PA; Mathy MJ; Thoolent MJ; Wilffert B; de Jonge A; Timmermans PB
J Hypertens Suppl; 1984 Dec; 2(3):S539-41. PubMed ID: 6599713
[TBL] [Abstract][Full Text] [Related]
19. Potent alpha-adrenoceptor blocking action of SGB-1534, a new quinazoline antihypertensive agent in vitro experiments.
Shibata S; Satake N; Suh TK; Ishida Y; Ueda S; Follmer C; Flores F
Gen Pharmacol; 1986; 17(2):143-9. PubMed ID: 2870954
[TBL] [Abstract][Full Text] [Related]
20. Urethane inhibits cardiovascular responses mediated by the stimulation of alpha-2 adrenoceptors in the rat.
Armstrong JM; Lefèvre-Borg F; Scatton B; Cavero I
J Pharmacol Exp Ther; 1982 Nov; 223(2):524-35. PubMed ID: 6127404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
